| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 0 | 5.90% | — | 6 months |
| Elbrus Investments Pte. Ltd. | 0 | 4.80% | — | 6 months |
| LAV Biosciences Fund IV, L.P. | 0 | 4.70% | — | 6 months |
| Prime Capital Funds | 0 | 7.10% | — | 6 months |
| Rock Springs Capital Master Fund LP | 0 | 1.20% | — | 6 months |
| SCC Growth V Holdco L, Ltd. | 0 | 14.20% | — | 6 months |
| Seacliff (Cayman) Ltd. | 0 | 4.80% | — | 6 months |
| Vivo Funds | 0 | 3.60% | — | 6 months |
| 惠理基金管理香港有限公司 | 0 | 7.10% | — | 6 months |
| 景林资产管理有限公司 | 0 | 4.70% | — | 6 months |
This page shows allotment analysis for Innovent Bio (01801): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

